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Abstract: Biofilm matrices of two Klebsiella pneumoniae clinical isolates, KpTs101 and KpTs113,
were investigated for their polysaccharide composition and protective effects against antimicrobial
peptides. Both strains were good biofilm producers, with KpTs113 forming flocs with very low
adhesive properties to supports. Matrix exopolysaccharides were isolated and their monosaccharide
composition and glycosidic linkage types were defined. KpTs101 polysaccharide is neutral and
composed only of galactose, in both pyranose and furanose ring configurations. Conversely, KpTs113
polysaccharide is anionic due to glucuronic acid units, and also contains glucose and mannose
residues. The susceptibility of the two strains to two bovine cathelicidin antimicrobial peptides,
BMAP-27 and Bac7(1–35), was assessed using both planktonic cultures and biofilms. Biofilm matrices
exerted a relevant protection against both antimicrobials, which act with quite different mechanisms.
Similar protection was also detected when antimicrobial peptides were tested against planktonic
bacteria in the presence of the polysaccharides extracted from KpTs101 and KpTs113 biofilms,
suggesting sequestering adduct formation with antimicrobials. Circular dichroism experiments
on BMAP-27 in the presence of increasing amounts of either polysaccharide confirmed their ability to
interact with the peptide and induce an α-helical conformation.
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1. Introduction
An increasing number of pathogens are acquiring multi drug resistance (MDR) to different classes
of antibiotics, a particularly relevant issue for infections acquired in hospital settings. The European
Centre for Disease Prevention and Control reported that in 2009, MDR infections caused 25,000 deaths
in Europe and estimated an economic burden, resulting from healthcare costs and productivity losses,
of at least €1.5 billion [1]. Today, due to the increase of antimicrobial resistance, these numbers are
likely to be considerable higher. Bacterial species under observation include several Gram-negative
ones, like Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii.
The current antibiotics arsenal comprises about 150 molecules from 17 different classes, but
each of these has seen resistance development in bacteria by several possible mechanisms including:
inactivation of the molecule itself, its expulsion, alteration of its target site, or reduced accessibility to
the target. The latter mechanism is exacerbated by biofilm formation: biofilm matrices exert a protective
role towards embedded microorganisms [2], obliging an increase in antimicrobial doses.
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Antimicrobial (host defence) peptides (AMPs), widespread effectors of the innate immune
response in animals, are promising leads to develop novel anti-infective agents with alternative
mechanisms to drugs in clinical use. In addition to direct killing of pathogens, they can also help
recruit immune cells to the site of infection and neutralize the pro-inflammatory effects of endotoxins.
They have multimodal killing mechanisms, involving interaction with bacterial components different
to those targeted by conventional antibiotics [3]. This multimodal action by a single molecule makes
acquisition of resistance more difficult, requiring concurrent multiple alterations in different targets.
AMPs have a recognized potential for generating new agents effective against MDR and/or biofilm
producing pathogens, and may be particularly useful at preventing colonization of abiotic surfaces in
medical devices, such as ventilators or catheters, which are potential sources of infection.
This paper describes a study on K. pneumoniae focused on the definition of its biofilm forming
potential as well as on the structural characterization of the polysaccharides present in the biofilm
matrix and on the evaluation of the activity of selected AMPs in the presence of biofilms. K. pneumoniae
is well known to produce 77 different capsular polysaccharides (K-antigens) and 8 basic types of
O-antigens. K-antigens are recognized virulence factors and exhibit protecting effects by contributing
to the evasion of innate immunity mechanisms, such as the action of AMPs [4–6], which are usually
investigated mainly with a focus on planktonic bacteria [7]. In addition, the anti-biofilm activity of
AMPs or their derivatives has been described [8]. Despite the numerous studies on structure and
function of K-antigens, very little information is reported about the K. pneumoniae polysaccharides
constituting the biofilm matrix.
In the present study, clinical isolates of K. pneumoniae were collected and their cultures,
obtained both in planktonic and biofilm mode, were investigated in the presence of BMAP-27 and
Bac7(1–35), bovine AMPs belonging to the cathelicidin family of host defence peptides. The former
is a membranolytic peptide with helical active form [9], while the latter is the 1–35 fragment of the
Pro-rich extended bactenecin Bac7, which can penetrate into susceptible Gram-negative bacteria and
inactivate cytoplasmic targets [10]. The selection of these two AMPs was dictated by their different
mechanism of action. To deeper investigate the effect of the matrix on AMP’s action, two isolates with
diverse characteristics were chosen: abundant matrix production within biofilm (BF) or flocs, and the
presence of polysaccharides exhibiting very different chemistry.
2. Materials and Methods
2.1. Bacterial Strains and Culture Conditions
Two strains of K. pneumoniae were chosen among 30 not-correlated clinical isolates (data not
shown) for their ability to form either a biofilm (BF) strongly attached to polystyrene (namely strain
KpTs101) or a “floating” biofilm (namely strain KpTs113). All strains were stored at ´80 ˝C in Luria
Broth (LB) medium containing 9% DMSO. Biofilm production and antimicrobial activity assays were
carried out by incubating bacteria in Müller–Hinton Broth (MHB) at 37 ˝C.
2.2. Antimicrobial Peptides
BMAP-27, Bac7(1–35) and its BODIPY fluorescently labelled derivative (Bac7(1–35)-BY) were
prepared by solid phase peptide synthesis, and purified, as previously described [11,12]. BMAP-27 is
a C-terminally amidated AMP with the following sequence: GRFKRFRKKFKKLFKKLSPVIPLLHL–am.
Like its close analogue BMAP-28, this type of linear cathelicidin undergoes a transition from
a disordered coil conformation to the biologically active α-helical one in the presence of anisotropic or
membrane-like environments [13,14]. Bac7(1–35) consists of an N-terminal, 35 residue fragment of
a proline rich peptide of 69 residues, and has the following sequence; RRIRPRPPRLPRPRPRPLPFPRP
GPRPIPRPLPFP–OH.
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2.3. Evaluation of the Antimicrobial Activity of Peptides against Planktonic Cells
The bacterial inoculum was incubated overnight in MHB with shaking, then diluted 1:30 in fresh
MHB and incubated with shaking for approximately 2 h to the mid-log phase, before resuspending to
the appropriate dose, according to the optical density (OD).
Minimum inhibitory concentration (MIC) determinations were carried out in MHB on mid-log
phase bacteria (1–5 ˆ 105 CFU/mL, CFU: colony-forming units) as previously described [7]. The MIC
was taken as the lowest concentration of antimicrobial peptide resulting in the complete inhibition of
visible growth after 24 h of incubation.
To assess growth inhibition, bacterial growth curves were also determined using mid-log phase
bacteria, starting at 1 ˆ 106 CFU/mL in MHB, in the presence of increasing peptide concentrations,
monitoring the optical density at 620 nm every 10 min at 37 ˝C for 4 h in a microplate reader with
intermittent shaking (Tecan Trading AG, Männendorf, Switzerland).
2.4. Biofilm Assays
Each strain was cultured overnight in MHB, diluted 1000ˆ in the same medium and inoculated
in a 96 wells polystyrene microtiter plate (200 µL/well carried out in triplicate). After 24 h of static
incubation, the culture suspensions were removed and each well was gently rinsed with 200 µL of
sterile saline solution. After 1 h further incubation at 60 ˝C to fix the BF, each well was stained with
200 µL of crystal violet 2% (CV) (Sigma, Saint Louis, MO, USA) for 15 min, rinsed with water and
dried at room temperature. The amount of CV bound to BF was evaluated by measuring the OD at
570 nm after solubilisation in 200 µL of 33% acetic acid for 30 min. Results are reported as biofilm
index (BI), defined as the percentage ratio between the OD570 after CV solubilisation and the OD590 of
the bacterial suspension relative to the same well.
The antimicrobial activity of peptides on sessile cells was evaluated by the BF susceptibility
assay [15], with minor modifications. Briefly, the BF grown on peg lids immersed in 100 µL of bacterial
suspension—prepared as described above—was incubated in fresh medium containing serial dilutions
of antimicrobial peptides; after 24 h, it was rinsed three times with sterile saline, transferred in fresh
medium by centrifugation at 850ˆ g for 20 min and further incubated for 6 h. The biofilm inhibitory
concentration (BIC) was established as the lowest concentration that inhibited growth of detached cells
(OD590 < 0.05).
2.5. Confocal Microscopy (CLSM) Experiments
Biofilms were grown in 12-well chambers (ibidi GmbH, Planegg, Germany) for 24 h, gently rinsed
once with water and stained either with 0.1% w/v acridine orange after fixation by incubation at 60 ˝C
for 1 h or without fixation with the LIVE/DEAD BacLight Bacterial Viability Kit (Molecular Probes,
Eugene, OR, USA), according to the manufacturer’s instructions. After removing the silicone gasket,
coverslips were mounted and slides were examined by CLSM using a Nikon C1-SI confocal microscope.
The image stacks collected by CSLM were analysed with the EZ-C1 Free Viewer (Nikon Corporation,
Tokyo, Japan) and the Image J 1.47 (Wayne Resband, National Institutes of Health, Bethesda, MD,
USA) softwares. The biofilm architecture was analysed using the COMSTAT software package [16].
Results are the mean of three independent experiments ˘ standard deviation.
2.6. Flow Cytometric Analysis
Flow cytometric assays were performed with a Cytomics FC 500 instrument (Beckman-Coulter, Inc.,
Fullerton, CA, USA) equipped with an argon laser (488 nm, 5 mW) and photomultiplier tube
fluorescence detectors. Filtered light wavelength was set at 610 nm for Propidium Iodide (PI) (Sigma,
Saint Louis, MO, USA) detection and at 525 nm for BODIPY (BY) detection. All detectors were set
on logarithmic amplification. Optical and electronic noise were eliminated by setting an electronic
gating threshold on the forward scattering detector, while the flow rate was kept at a data rate below
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300 events/second to avoid cell coincidence. For each sample, at least 10,000 events were acquired and
stored as list mode files.
For the uptake evaluation, cultures of mid-log phase bacteria, diluted to 1ˆ 106 CFU/mL in MHB,
were incubated at 37 ˝C for 10 min with 0.25 µM Bac7(1–35)-BY; after incubation, treated bacterial
cells were washed three times in buffered high salt solution (10 mM sodium phosphate, 400 mM
NaCl, 10 mM MgCl2, pH 7.2) in order to remove the fraction of peptide bound to the cell surfaces,
and immediately analysed by the flow cytometer with or without a 10 min pre-incubation at room
temperature with 1 mg/mL of the quencher Trypan Blue (TB) [17].
Integrity of the bacterial cell membrane was assessed by measuring the PI uptake by flow
cytometry, as previously described [18]. Briefly, mid-log phase bacterial cultures, diluted at
1 ˆ 106 CFU/mL in MHB, were incubated at 37 ˝C for different times with different concentrations
of BMAP-27. PI was added to all samples at a final concentration of 10 µg/mL and after incubation,
bacterial cells were analysed by flow cytometry.
Data analysis was performed with the FCS Express 3 software (De Novo Software, Los Angeles,
CA, USA).
2.7. Biofilm Production and Extraction and Purification of Exopolysaccharides
K. pneumoniae strains Ts113 and Ts101 were grown on cellulose membranes deposited on solid
agar medium [19]. Cellulose membranes (Sigma, cut-off 14,000 Da) were cut in a circle the size of the
Petri dish (90 mm diameter), washed first in a boiling 5% Na2CO3 solution for 15 min and then in
boiling water for 15 min, autoclaved and placed over Petri dishes, containing Müller–Hinton (MH)
solid medium. The excess of water was removed before seeding the bacteria. Thirty plates were used
for each strain. Two spots of 10 µL of overnight liquid cultures in MH broth were deposited on the
cellulose membranes and after 2 days of incubation at 30 ˝C, the material from each Petri dish was
scraped from the membrane and recovered in 3–5 mL of 0.9% NaCl. The suspensions were centrifuged
at 48,000ˆ g at 4 ˝C for 20 min, and filter-sterilized (Millipore membranes 0.22 µm). UV spectroscopy
showed the absence of proteins and nucleic acids. The solutions containing KpTs113 and KpTs101
polysaccharides were dialyzed first against 0.1 M NaCl, then water, taken to pH = 6.8 and pH = 6.7,
respectively and recovered by lyophilisation. They were named EPOL Kp113 and EPOL Kp101.
2.8. Exopolysaccharides Composition and Glycosidic Linkages Determination
For the determination of polysaccharides composition two methods were used: (i) for neutral
saccharides detection, the polysaccharides were hydrolysed with 2 M trifluoroacetic acid (TFA) at
125 ˝C for 1 h, followed by derivatisation of the monosaccharides to alditol acetates [20]; (ii) for
uronic acid detection, the polysaccharides were subjected to methanolysis with 2 M HCl in methanol
at 85 ˝C for 16 h, followed by derivatisation of the methyl glycosides mixtures to trimethylsilyl
derivatives (TMS) using the reagent Sylon™ HTP (Sigma) [21]. The products were analysed by
Gas-Liquid Chromatography GLC on a PerkinElmer Autosystem XL (PerkinElmer, Waltham, MA,
USA) gas chromatograph equipped with a flame ionisation detector, a capillary column and using
He as carrier gas. Alditol acetates were separated on a SP2330 column (Supelco, 30 m) with the
temperature program: 200–245 ˝C at 4 ˝C/min, while for the TMS methyl glycosides a HP-1 column
(Hewlett Packard, 30 m, Agilent Technologies, Santa Clara, CA, USA) was used with the temperature
program: 150–280 ˝C at 3 ˝C/min. The glycosidic linkages determination was achieved by methylation
analysis. The lyophilized sample was permethylated [22], hydrolysed with 2 M TFA for 1 h at 125 ˝C,
the products reduced to alditol with NaBH4 and subsequently peracetylated [20] to obtain partially
methylated alditol acetates derivatives. The mixture was analysed by GLC using a SP2330 or a HP-1
capillary columns. In order to quantify each sugar derivative, peak areas were corrected by the effective
carbon response factor [23]. The mixture of partially methylated alditol acetates was also analysed by
GLC-MS (MS = Mass spectrometry) using an Agilent Technologies 7890A gas chromatograph coupled
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to an Agilent Technologies 5975 C VL mass spectrometry detector, equipped with the same capillary
columns and using He as carrier gas. The temperature program used was: 150–250 ˝C at 4 ˝C/min.
2.9. Circular Dichroism Experiments
Circular dichroism spectra were obtained using a J-600 spectropolarimeter (JASCO Europe s.r.l.,
Cremella, Italy), using a 2 mm optical path quartz cuvette thermostatted at 25 ˝C. Measurements were
carried out at constant BMAP-27 concentration (20 µM) in the presence of increasing amounts of
polysaccharide: EPOL Kp113 from 0 to 400 µM, moles of pentasaccharide; EPOL Kp101 from 0 to
380 µM, moles of pentasaccharide in phosphate buffer (10 mM, pH 7.4). The concentration is given in
terms of pentasaccharide units, since it is the repeating unit of EPOL Kp113 polysaccharides and used
also for EPOL Kp101 which contains only galactose, to allow direct comparison.
3. Results
3.1. Strains Description
The biofilm forming ability of 30 K. pneumoniae clinical isolates was evaluated by the crystal
violet procedure and they were divided into three classes as a function of the BF index (BI): excellent:
BI ě 95th percentile [24], good: BI between the 95th and the 50th percentile, and scarce: BI < 50th
percentile. Preliminary evaluation of the susceptibility of planktonic forms towards the bovine AMPs
Bac7(1–35) and BMAP-27 was carried out using the microbroth dilution method, allowing the set-up of
further analyses (Table 1). The protective effect of BF towards Bac7(1–35) and BMAP-27 was tested by
the biofilm inhibitory concentration (BIC) assay that gives information about protection conferred by
the whole matrix. Except for strain KpTs12, results showed that sessile cells were much less susceptible
to the peptides’ action than the planktonic ones (Table 1), even in the case of KpTs113, whose BF has
very poor adhesive properties.
Table 1. Biofilm production and susceptibility to antimicrobial peptides (AMPs) of K. pneumoniae strains.
BF 1
Production
No. of Strains RepresentativeIsolate BF Index
Bac7(1–35) BMAP-27
MIC BIC MIC BIC
Excellent 2
KpTs101 145 2 64 2 >64
KpMn7 101 4 32 4 64
Good 15
ATCC 700603 76 4 32 4 64
KpTs107 67 4 16 4 >64
Scarce 13
KpTs12 13 4 8 4 16
KpTs109 13 4 32 4 32
Flocs 1 KpTs113 - 2 64 2 >64
1 The ability to form biofilm of 30 clinical isolates and of ATCC 700603 strain was evaluated by the crystal violet
method and categorized into three groups on the basis of the resulting biofilm index (BI). Excellent: BI ě 95th
percentile; Good: 50th percentile ď BI < 95th percentile; Scarce: BI < 50th percentile. Flocs: see description of
strain KpTs113 in the text. Susceptibility of planktonic and sessile cells of two strains representative of each
group was evaluated by means of minimum inhibitory concentration (MIC) and biofilm inhibitory concentration
(BIC), respectively. Inhibitory concentrations are expressed as µM.
Two strains, both collected from urine samples, were selected for this study: one was the best
biofilm producer (KpTs101) and the second one was able to produce abundant extracellular matrix,
but with very low adhesion ability (KpTs113). In fact, when cultured in a liquid medium containing
a glass slide, KpTs113 formed flocs [25], which detached when the slide was taken out and rinsed.
Confocal microscopy, after staining with acridine orange, evidenced a large difference in the quantity
of biomass adhering to the glass for the two strains (Figure 1). As a consequence, the biofilm forming
ability of the KpTs113 strain was largely underestimated by the CV assay on microtiter plates, where
most of the biofilm was probably lost on rinsing.
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Figure 1. Total biofilm produced by KpTs101 (A); and KpTs113 (B) on glass slides. After 24 h growth 
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with the two K. pneumoniae strains, over a shorter period of time (240 min) and in the presence of a 
range of sub-inhibitory to inhibitory concentrations of Bac7(1–35) and BMAP-27, by measuring the 
optical density of bacterial cells suspension (Figure 2). According to the similar MIC values obtained, 
no significant differences of susceptibility to Bac7(1–35) were evident for the two strains considered. 
Bac7(1–35) had inhibiting effects on bacterial growth also at sub-inhibitory concentrations  
(0.5–1 µM), and these were still detectable even at 0.25 µM (Figure 2a,c). Similarly, bacterial growth 
of KpTs101 and KpTs113 was slowed in the presence of 0.25–0.5 µM BMAP-27, significantly 
decreased at a peptide concentration of 1 µM, and totally inhibited at 2 µM (Figure 2b,d). From the 
growth kinetic data, IC50 (IC50: concentration required for 50% inhibition) values of the two peptides 
were calculated: Bac7(1–35) had IC50 of 0.2–0.3 µM and BMAP-27 of 0.6–0.7 µM, for both Klebsiella 
strains. 
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fluorescence intensity was not reduced by the TB quencher (<10% quenching) (Figure 3), indicating a 
rapid uptake of Bac7(1–35) by both strains and suggesting a substantial intracellular localization of 
the peptide. The mean fluorescence intensity (MFI) values for the KpTs113 strain were higher than 
for KpTs101, in agreement with the higher susceptibility observed for KpTs113 strain in MIC and 
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Figure 1. Total biofilm produced by KpTs101 (A); and KpTs113 (B) on glass slides. After 24 h growth the
biofilms were fixed and stained with acridine ora ge 1% w/v. Z-stacks were acquired with a 20ˆ/0.5
air objective at 1 µm intervals. Orthogonal views of Z-stacks are shown in the right and lower sides of
each frame.
3.2. Growth Kinetic Assays
IC assays (Table 1) are not a very sensitive way of comparing antibacterial activity for A Ps,
on different bacterial strains as they are based on serial dilutions, and furthermore, even if only just
a few bacteria survive at a given peptide concentration on overnight culture, these can eventually
grow and mask any difference in susceptibility. Therefore, growth kinetics assays were carried out
with the two K. pneumoniae strains, over a shorter period of time (240 min) and in the presence of
a range of sub-inhibitory to inhibitory concentrations of Bac7(1–35) and BMAP-27, by measuring the
optical density of bacterial cells suspension (Figure 2). According to the similar MIC values obtained,
no significant differences of susceptibility to Bac7(1–35) were evident for the two strains considered.
Bac7(1–35) had inhibiting effects on bacterial growth also at sub-inhibitory concentrations (0.5–1 µM),
and these were still detectable even at 0.25 µM (Figure 2A,C). Similarly, bacterial growth of KpTs101
and KpTs113 was slowed in the presence of 0.25–0.5 µM BMAP-27, significantly decreased at a peptide
concentration of 1 µM, and totally inhibited at 2 µM (Figure 2B,D). From the growth kinetic data, IC50
(IC50: concentration required for 50% inhibition) values of the two peptides were calculated: Bac7(1–35)
had IC50 of 0.2–0.3 µM and BMAP-27 of 0.6–0.7 µM, for both Klebsiella strains.
3.3. Evaluation of Bac7(1–35) Uptake in K. pneumoniae Strains
To investigate the correlation between the observed antimicrobial activity of Bac7(1–35) against
K. pneumoniae with its internalization, the level f uptake of the fluorescent derivative Bac7(1–35)-BY
into bacterial cell wa evaluated. Peptid -treated bacteria wer incubated with the quencher Trypan
Blue (TB), which doe not pen trat into und maged cells and ca thus quenc t fl orescence only
of extracellular and accessible dye-conjugate peptide. Upon tre ting KpTs101 and KpTs113 cells with
sub-inhibitory and non-perm abilizing conc ntrations of Bac7(1–35)-BY for 10 min, the fluorescence
intensity was not reduce by the TB quencher (<10% quenchi g) (Figure 3), indicating a rapid uptak
of Bac7(1–35) by both strai s an suggesting a substantial intracellular localization of the peptide.
The mean fluorescence intensity (MFI) values for the KpTs113 strai were higher than for KpTs101,
in agreement with the higher usceptibility observed for KpTs113 strain in MIC a d growth kinetics
assays (see Table 1 and Figure 2A,C).
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peptides, and the OD620 was measured every 10 min. The results are the means of three independent 
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Figure 3. Evaluation of Bac7(1–35) internalization into K. pneumoniae Ts101 and Ts113 strains. 
Fluorescence of KpTs101 and KpTs113 cells exposed for 10 min to 0.25 µM Bac7(1–35)-BY was 
reported. Bacterial cells (1 × 106 CFU/mL) were incubated with peptide, extensively washed, and 
analyzed by flow cytometry with (grey columns) or without (white columns) incubation with  
1 mg/mL TB for 10 min at 37 °C. Data are expressed as the average of mean fluorescence intensity 
(MFI) ± SD from three independent experiments. 
Figure 2. Growth kinetics of KpTs101 a 13 strains in pr sence of Bac7(1–35) or BMAP-27.
Bacterial suspensions (106 cells/ ) ere grown for 4 h in presence of the in icated concentrations
of peptides, and the OD620 was measured every 10 min. The results are the means of three
independent experiments. (A) KpTs101/Bac7(1–35); (B) KpTs101/BMAP-27; (C) KpTs113/Bac7(1–35);
(D) KpTs113/BMAP-27.
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Figure 3. Evaluation of Bac7(1 ) i t r lization into K. pneumoniae Ts101 and Ts113 strains.
Fluorescence of KpTs101 and KpTs113 cells exposed for 10 min to 0.25 µM Bac7(1–35)-BY was reported.
Bacterial cells (1 ˆ 106 CFU/mL) were incubated with peptide, extensively washed, and analyzed by
flow cytometry with (grey columns) or without (white columns) incubation with 1 mg/mL TB for
10 min at 37 ˝C. Data are expressed as the average of mean fluorescence intensity (MFI) ˘ SD from
three independent experiments.
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3.4. Effect of BMAP-27 on Bacterial Membrane Integrity
The permeabilizing effect of membrane-active BMAP-27 was evaluated in planktonic
K. pneumoniae cells by the PI-uptake assay (Figure 4). For the KpTs101 strain, membrane damage was
evident after 30 min of treatment, even at a concentration below its MIC: at 0.25 µM the percentage of
damaged cells was 30%–40%, and this value rose upon increasing the peptide concentration, showing
a clear dose-dependence (Figure 4, white columns). The percentages of PI-positive KpTs113 cells were
significantly lower than KpTs101 after treatment with 0.25 and 0.5 µM BMAP-27, and showed a dose
dependent pattern (Figure 4, grey columns). When treated with 1 µM BMAP-27, both strains reached
more than 70%–80% of PI-positive cells, indicating that the activity of this peptide is principally due to
its membranolytic effect (Figure 4).
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3.5. iofil For ation at Sub-Inhibitory oncentrations of s
s escribed above, K. pneumoniae cells exposed to sub-inhibitory concentrations of AMPs suffered
to a different extent, but part of the population remained viable and was able to reach the stationary
phase if incubated for 24 h. Therefore, their BF forming ability was tested under these conditions.
KpTs101 was grown for 24 h in microtiter wells in the presence of sub-inhibitory concentrations of
Bac7(1–35) or BMAP-27 and the amount f BF produced was evaluated by CV staining. Results were
expressed as BF index (Figure 5) in order to normalize the biomass produced with respect to bacterial
growth. At sub-inhibitory concentrations (0.25 µM), both AMPs caused about 40% significant decrease
in BF formation ones. It is noteworthy that, however, at higher concentrations, although the BF index
increased, a larger variability am g independent experiments was observed, probably due to the
diffic lty of the strains to grow at concentrations close t the MIC values, so it was ot possible assess
with significance if the BF was decreased (Bac7(1–35)) or even increased (BMAP-27).
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3.6. Characterisation of the Biofilm Matrix Polysaccharide Produced by KpTs101 and KpTs113
Bacterial polysaccharides are considered the main component of biofilm matrices. On the one
hand they are responsible for the setting-up of the macromolecular scaffold embedding bacterial cells.
On the other hand, they may exhibit interesting biological activity due to their specific structural
characteristics. For this reason, polysaccharides produced by the two K. pneumoniae strains were
isolated from biofilms. After growing bacteria on semipermeable cellulose membranes, about 50 mg
of polysaccharide produced by KpTs101 and 15 mg by KpTs113 were recovered and the samples
were named EPOL Kp101 and EPOL Kp113, respectively. Their chemical characterization is hereafter
briefly reported.
EPOL Kp101. Composition analysis as alditol acetate and trimethylsilyl methyl-glycosides
(TMS) derivatives showed the presence o ly of galactose (Gal). The determination of the linkage
position showed both 3-linked Gal and 3-linked Galp. These results indicated that EPOL Kp101 is
a neutral polysaccharide composed of Gal in bo h fur nose and pyranose ring structures. In addition,
preliminary NMR investigation strongly indicated that it is a mixtur of two D-galactan polymers
(unpublished results) identical to the O-antigen polysaccharides of K. pneumoniae serotype O1 [26].
EPOL Kp113. Recent investigations carried out in our laboratory demonstrated that the EPOL
Kp113 structure [27] is identical to the K24 capsular polysaccharide [28]. The structure is reported in
Scheme 1.
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each of EPOL Kp101 and EPOL Kp113 purified from matrices. Data are reported in Table 2 (Ps column)
together with MIC and BIC values from Table 1 for an easy comparison. The results do indicate that
polysaccharides significantly contribute to the protective action of the matrix. To further investigate
this protection mechanism, we then determined if the matrix polysaccharide interacted with the helical
AMP BMAP-27 by monitoring its effect on peptide structure, using circular dichroism.
Table 2. Antimicrobial activity of Bac7(1–35) and BMAP-27 towards KpTs101 and KpTs113
K. pneumoniae isolates. Activities are given as MIC for planktonic cells, as BIC for biofilms, and
as MIC in the presence of matrix polysaccharides (Ps).
Strain
Bac7(1–35) BMAP-27
MIC 1 BIC 1 Ps 2 MIC 1 BIC 1 Ps 2
KpTs101 2 64 32 2 >64 64
KpTs113 2 64 32 2 >64 64
1 MIC and BIC are expressed in µM; 2 Ps, MIC in the presence of 1 mg/mL of polysaccharide purified from
the matrix.
3.8. Circular Dichroism (CD) Spectroscopic Study
The spectroscopic analysis was limited to BMAP-27 because it undergoes a transition from
a random conformation to an active amphipathic α-helix in anisotropic and membrane-like
environments, and this is likely correlated with its membranolytic activity [29]. Conversely, bactenecins
do not show an altered conformation in the presence of membranes, or produce membrane lysis
at active concentrations [19,30]. For helix-forming cathelicidins, the disordered coil conformation
facilitates the approach to the membrane where they undergo the transition to an amphipathic helix
conformation, allowing insertion of the hydrophobic sector into the lipid bilayer and subsequent
membrane lysis via either or both a carpeting and toroidal pore mechanism [31,32]. The data collected
here (Figure 6) indicates that also in the presence of both EPOL Kp101 and EPOL Kp113 the peptide
underwent a conformational transition to a helical conformation. Concentration-dependent) helix
induction in the presence of polysaccharide is direct evidence of the formation of a complex between
the two species, and by analogy to what occurs with primate helical cathelicidins, this can lead to
a sequestering effect that impedes the approach to the bacterial cytoplasmic membrane [31–33].
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Figure 6. Concentration-dependent circular dichroism spectra of BMAP-27 as a function of increasing
amount of (A) EPOL Kp113; and (B) EPOL Kp101. [BMAP-27] = 20 µM. Polysaccharide concentrations:
EPOL Kp113 from 0 to 400 µM, moles of pentasaccharide; EPOL Kp101 from 0 to 380 µM, moles of
pentasaccharide. Solvent: phosphate buffer 10 mM, pH 7.4.
Figure 6 clearly shows the transition from a peptide disordered conformation to α-helices, whose
CD spectrum is typically characterized by a double negative absorption bands centred approximately
at 210–222 nm. Based on the method of Chen et al. [34] the helix content is close to 100% in the presence
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of EPOL Kp101 and close to 90% in the presence of EPOL Kp113. The strong helix-inducing capacity
of the polysaccharides suggests that the interaction with the peptide itself is strong. Furthermore, it
is not just of on electrostatic nature, as the neutral polysaccharide has the greater capacity to insure
helix formation.
3.9. Confocal Microscopy of KpTs101 Biofilms
The effect of high concentrations of AMPs on the architecture of a mature KpTs101 biofilm was
investigated with confocal microscopy by examining a 24 h grown BF treated with 64 µM AMPs.
The BF was stained with a Syto9/PI mix to distinguish live from dead cells (Figure 7). In these
conditions, BMAP-27 displayed an evident crumbling effect compared to the control (Figure 7C).
The biofilm height was reduced by 36% ˘ 6%, the total biomass was reduced by 75% ˘ 0.2% (with
87% ˘ 5% decrease in total live cells), and the roughness coefficient increased 5 ˘ 0.2 times for live
cells and up to 24 ˘ 1 times for dead cells, highlighting the scattered distribution of the structure.
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Figure 7. 3D images of KpTs101 BF treated with AMPs. The biofilm formed after 24 h growth by
KpTs101 on glass was incubated for further a 24 h in saline solution alone (A); or with addition of
64 µM Bac7(1–35) (B); or BMAP-27 (C), gently washed and stained with the live/dead kit: live bacteria
were stained green and dead bacteria were stained red. Z-stacks were acquired with a 60ˆ/1.4 oil
objective at 0.33 µm intervals.
Treatment with 64 µM Bac7(1–35) (Figure 7B) caused reduction of the biofilm height by 21%˘ 14%
with respect to the cont ol (Figur 7A) while the biomass was apparently not affected. The roughness
oefficient displayed a significant increase (more than 100 times), strongly suggesting that the treated
structure was denser than t e control. In particular, he populati n of d ad cells was more represented
in t e bottom section of the biofilm. In fact, although many dead cells are usually present in the lower
stacks, in the observed specimens 40% ˘ 4% of red staining was detected in the lowest q arter of the
structure, while 29% ˘ 0.4% was measured in the same portion of t e control sample.
4. Discussion
Biofilm matrices are complex gel-like systems where biopolymers setup a network embedding cells
and favouring proximity of interacting micro- and macro-molecular species. Among macromolecules,
polysaccharides are considered to be the most relevant components to matrices architecture. This is
due to their strong ability to interact within each other and with different macromolecules including
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proteins and extracellular DNA, to form the BF scaffold. Furthermore, polysaccharides may also exhibit
specific biological properties which contribute to the protection offered to bacteria by biofilm matrices.
In this study, we analysed the influence of sub-inhibitory concentrations of Bac7(1–35) and
BMAP-27 antimicrobial peptides on the biofilm forming capacity of two clinical isolates of K. pneumoniae
and the protection exhibited by the matrices against these AMPs. In addition, the composition
of exopolysaccharides present in the matrices was defined and the effect of their interaction with
antimicrobial peptides was related with the protective effect.
The two K. pneumoniae isolates used for this investigation were chosen after screening over
30 strains exhibiting high variability in BF production. In particular, KpTs101 and KpTs113, although
good BF producers, showed very different BF-adhesion properties: KpTs101 produced a biofilm
strongly adhering to supports, whereas KpTs113 produced flocs. Therefore, all experiments that
required adhesion to a surface were conducted only on KpTs101.
The adhesion properties of K. pneumoniae have been related to both type 3 fimbrial proteins and
lipopolysaccharides [35]. Therefore, it can be speculated that the two strains investigated might exhibit
differences in these molecular components. However, their role might be developed in synergy with
matrix polysaccharides. In this study we demonstrated that the EPOL constituting the matrix are
chemically very different. EPOL Kp101 is neutral and composed only of Gal residues. Interestingly,
sugar rings are present both in the furanose and pyranose structures, indicating possible peculiar
conformational features which might influence the overall polymer chain rigidity. On the contrary,
EPOL Kp113 is a branched polysaccharide composed of mannose and glucose residues together with
glucuronic acid. Thus, the negative charge exhibited by the polysaccharide might contribute to the
scarce BF-matrix adhesion properties.
Sub-inhibitory concentrations of Bac7(1–35) and BMAP-27 affected biofilm production in
a different manner, probably due to their different mechanism of action. Bac7(1–35) caused a decrease
of biofilm production, even at much lower concentrations than MIC values (Figure 5A). This AMP is
internalised and inhibits bacterial metabolism. Therefore, it can be speculated that bacteria, whose
growth is partially inhibited (Figure 2A), are not able to release great amounts of exoproducts thus
diminishing biofilm production. On the contrary, the effect of BMAP-27 treatment was more complex
(Figure 5B) and dependent on the concentration used. At low concentration it inhibited biofilm
production, but approaching the MIC value it induced an opposite effect, determining a higher amount
of exoproducts. However, it is worth noting that results are expressed as biofilm index, i.e., the amount
of biofilm normalised for bacterial growth. The results obtained suggest that at concentration very close
to the MIC cells that remain able to grow must face a very hostile environment (indicated by the high
variability detected among independent experiments) and synthesise larger amount of exoproducts
than usual, probably in the attempt to protect themselves.
The investigation of the susceptibility of the two K. pneumoniae strains to antimicrobial peptides
was preceded by the assessment of their mechanisms of action. Bac7(1–35) exerts its action by
internalization and in fact flow cytometry assays (Figure 3) showed an effective internalization for both
strains. BMAP-27 acts as bacterial membrane disruptor and flow cytometry experiments indicated
that only at high AMP doses were both strains subjected to similar membranolytic effects (Figure 4).
In the 0.25–0.50 µM range for BMAP-27, KpTs101 was subjected to membrane lysis to a greater extent
than KpTs113. The susceptibility assays carried out with KpTs101 and KpTs113 in the presence of
Bac7(1–35) and BMAP-27 proved the relevant protecting effect of biofilm, which enhanced resistance
of embedded cells compared to the planktonic ones by about 30 times towards Bac7(1–35) and even
more towards BMAP-27 (Table 1).
Surprisingly, investigating the effect of high concentrations of AMPs on the architecture of the
biofilm gave opposite results (Figure 7), showing an intense crumbling effect by BMAP-27 compared
to a moderate collapsing effect of Bac7(1–35). However, these experiments were conducted in saline
solution where cells, blocked in the stationary phase, undergo the AMP’s action without opposing
resistance. Compared to BIC evaluation, this condition weakens the effect of Bac7(1–35), which is
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almost inactive on non-replicating cells and only at high concentrations does it exert a moderate
bacteriolytic effect which causes a sort of “precipitation” of dead cell to the deep layers of the biofilm.
On the contrary, when mature biofilm under low-nutrient conditions was exposed to very high
concentrations of BMAP-27, an evident disruption of the biomass was detected.
5. Conclusions
It is worth stressing that susceptibility assays carried out in the presence of polysaccharides
extracted from BF of the two strains resulted in MIC values comparable to the BIC values obtained in
the presence of native biofilms (Table 2, columns Ps). This protective effect shown by the extracted
BF polysaccharides towards AMPs strongly suggested a direct interaction of the two molecular
species. The interaction could be easily demonstrated for BMAP-27, via circular dichroism experiments
carried out in phosphate buffer solutions, as it underwent a conformational transition from random
coil to helical in the presence of both EPOL Kp101 and EPOL Kp113. As previously stated, the
composition of the two exopolysaccharides is very different. The presence of the negatively charged
glucuronic acid in the EPOL Kp113 could explain its helix-promoting activity in terms of electrostatic
interactions with the cationic peptide. In fact, the formation of the amphipathic helix positions all
cationic residues on the same side of the helix cylinder, thus increasing the efficiency of electrostatic
interactions. The formation of secondary structure upon interaction with increasing concentrations
of EPOL Kp113 nicely explains the decreased susceptibility of polysaccharide embedded cells with
respect to planktonic ones, as it favours peptide self-aggregation and impedes proper contact with
the bacterial surfaces [36]. Quite surprisingly, however, the neutral EPOL Kp101, exhibited an even
better capacity to induce helix formation, indicating that interactions other than the electrostatic ones
(e.g., H-bonding, hydrophobic and van der Waals interactions) are involved in the complexation with
BMAP-27. In conclusion, both polysaccharides which contribute to the biofilm matrix composition
exhibited a significant sequestering activity towards antimicrobial peptides with slightly different
chemical mechanisms.
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